With Refractory Leukemia 对于难治性白血病
refractory or relapsed acute leukemia 难治复发性急性白血病的
refractory acute myeloid leukemia 难治性急性髓系白血病
refractory and recurrent leukemia 难治复发性白血病
refractory-relapsed acute leukemia 复发难治性急性白血病
refractory chronic lymphocytic leukemia 难治性慢性淋巴细胞白血病
refractory acute nonlymphocytic leukemia 难治性急性非淋巴细胞白血病
acute refractory and recurrent leukemia 难治及复发性急性白血病
refractory and relapsed acute leukemia 难治及复发性急性白血病
Some patients still have AML cells in their marrow even after treatment. This is called refractory leukemia.
有些患者甚至在治疗后其骨髓中仍然存有aml细胞。这叫做难治性白血病。
With refractory leukemia, drugs that were not used to treat the patient's AML in the first part of treatment may be given. Stem cell transplantation also may be used.
对于难治性白血病，可能会用到在AML第一阶段治疗中用不到的药，也可能会进行干细胞移植。
Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
应用推荐